cached image

Lori Ferrins, Ph.D.

Affiliations: 
2015- Northeastern University, Boston, MA, United States 
Area:
Trypanosomiasis
Google:
"Lori Ferrins"
Mean distance: 9.62
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Klug DM, Tse EG, Silva DG, et al. (2023) Open Source Antibiotics: Simple Diarylimidazoles Are Potent against Methicillin-Resistant . Acs Infectious Diseases
Ferrins L, Buskes MJ, Kapteyn MM, et al. (2023) Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes. Frontiers in Microbiology. 14: 1304196
Boby ML, Fearon D, Ferla M, et al. (2023) Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science (New York, N.Y.). 382: eabo7201
Dichiara M, Simpson QJ, Quotadamo A, et al. (2023) Structure-Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis. Acs Infectious Diseases
Ferrins L, Buskes MJ, Kapteyn MM, et al. (2023) Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes. Frontiers in Microbiology. 14: 1149145
Sanders BC, Pokhrel S, Labbe AD, et al. (2023) Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2. Nature Communications. 14: 1733
Sanders B, Pokhrel S, Labbe A, et al. (2022) Potent and Selective Covalent Inhibition of the Papain-like Protease from SARS-CoV-2. Research Square
Klug DM, Mavrogiannaki EM, Forbes KC, et al. (2021) Lead Optimization of 3,5-Disubstituted-7-Azaindoles for the Treatment of Human African Trypanosomiasis. Journal of Medicinal Chemistry
Klug DM, Mavrogiannaki EM, Forbes KC, et al. (2021) Lead Optimization of 3,5-Disubstituted-7-Azaindoles for the Treatment of Human African Trypanosomiasis. Journal of Medicinal Chemistry
Dahlin JL, Auld DS, Rothenaigner I, et al. (2021) Nuisance compounds in cellular assays. Cell Chemical Biology
See more...